🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

KMC Speciality Hospitals (India) Limited KMCSHIL NSE

Company Profile ↓
₹138.24
-2.63% 1Y
Mkt Cap₹2,254.49 Cr
P/E48.17
P/B10.98
52W High₹141.97
52W Low₹133.19
Book Value₹12.90
EPS (TTM)₹2.87

Company Overview

KMC Speciality Hospitals (India) Limited (KMCSHIL) is a publicly traded company listed on NSE with a market capitalization of ₹2,254.49 Cr. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Strong Return on Equity

Generates a return on equity of 22.2%, reflecting efficient use of shareholder capital.

Healthy Capital Returns

Return on capital employed stands at 22.9%.

Consistent Profit Growth

Net profit has compounded at 20.5% per year over the last five years.

Steady Revenue Expansion

Revenue has grown at a 25.4% CAGR over the past five years.

Healthy Margins

Maintains a net profit margin of 15.3%.

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.40.

Recent Developments

  • Mar 2026 Revenue of ₹305.77 Cr (+32.0% YoY); net profit ₹46.73 Cr.
  • Trailing 12 Months Year-on-year growth — revenue +32.0%, earnings +118.1%.
  • 5-Year Trend Long-term compounding — revenue CAGR 25.4%, profit CAGR 20.5%.

Growth & Price Performance

Compounded Sales Growth

5 Years:25.45%
1 Year:32.03%

Compounded Profit Growth

5 Years:20.53%
1 Year:118.11%

Stock Price Performance

1 Year:-2.63%
6 Months:-
3 Months:-
1 Month:-

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot
52-Week Range 58% of range
₹133.19 ₹141.97
Price Performance
1Y-2.63%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

NSE TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Strong return on equity of 22.2%.
  • Healthy ROCE of 22.9%.
  • Compounding revenue at 25.4% over 5 years.
  • Profit CAGR of 20.5% over 5 years.
  • Generates positive free cash flow.

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
48.17
Industry PE
-
Forward P/E est.
24.09
PEG Ratio
-
Book Value
₹12.90
Price to Book
10.98
P/S
7.56
EV/EBITDA
25.20
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
25.45%
Profit 5Y
20.53%
Revenue (YoY)
32.03%
Earnings (YoY)
118.11%

Profitability & Returns

ROCE
22.89%
ROE
22.21%
ROA
14.07%
Profit Margin
15.28%
Op Margin
21.67%
Gross Margin
85.28%
EPS (Latest Qtr)
₹-
EPS (TTM)
₹2.87

Balance Sheet & Liquidity

Debt/Equity
0.40
Quick Ratio
1.81
Current Ratio
1.90
Debt
₹83.68 Cr
Total Assets
₹332.12 Cr
Current Assets
₹81.21 Cr
Working Capital
₹38.54 Cr

Ownership

Promoter Holding
77.49%
Chg in Prom Hold
-
FII / Inst Holding
0.00%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
₹2,254.49 Cr
Total Revenue (TTM)
₹305.77 Cr
EBITDA
₹93.00 Cr
Free Cash Flow
₹62.46 Cr
Operating Cash Flow
₹79.10 Cr
Shares Outstanding
₹16.31 Cr
Gross Margin
85.28%
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in INR.

Metric Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 60.93 Cr66.55 Cr74.90 Cr82.06 Cr82.25 Cr
Cost of Revenue 9.49 Cr10.36 Cr11.04 Cr11.45 Cr12.17 Cr
Gross Profit 51.45 Cr56.19 Cr63.87 Cr70.61 Cr70.09 Cr
Operating Expenses 41.10 Cr44.82 Cr48.33 Cr51.20 Cr50.16 Cr
Operating Income 10.34 Cr11.37 Cr15.54 Cr19.42 Cr19.93 Cr
EBITDA 16.21 Cr17.25 Cr22.09 Cr25.88 Cr27.78 Cr
Interest Expense 2.31 Cr2.16 Cr2.05 Cr2.07 Cr2.03 Cr
Pretax Income 8.82 Cr10.01 Cr14.74 Cr18.48 Cr19.80 Cr
Tax Provision 4.30 Cr2.47 Cr3.90 Cr4.75 Cr5.17 Cr
Net Income 4.52 Cr7.54 Cr10.84 Cr13.73 Cr14.63 Cr
Diluted EPS -----

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue -154.89 Cr175.42 Cr231.60 Cr305.77 Cr
Cost of Revenue -22.97 Cr24.42 Cr33.68 Cr45.01 Cr
Gross Profit -131.92 Cr150.99 Cr197.92 Cr260.76 Cr
Operating Expenses -97.50 Cr111.78 Cr159.99 Cr194.50 Cr
Operating Income -34.43 Cr38.16 Cr37.93 Cr66.25 Cr
EBITDA -44.44 Cr50.95 Cr59.97 Cr93.00 Cr
Interest Expense -81.10 L1.16 Cr9.42 Cr8.31 Cr
Pretax Income -35.99 Cr40.56 Cr31.60 Cr63.02 Cr
Tax Provision -9.30 Cr10.18 Cr10.18 Cr16.29 Cr
Net Income -26.69 Cr30.38 Cr21.43 Cr46.73 Cr
Diluted EPS -1.641.861.312.87

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets -181.65 Cr263.72 Cr286.00 Cr332.12 Cr
Current Assets -51.86 Cr33.52 Cr33.24 Cr81.21 Cr
Cash & Equivalents -1.84 Cr4.85 Cr9.19 Cr50.02 Cr
Inventory -2.27 Cr2.05 Cr3.50 Cr3.88 Cr
Receivables -4.37 Cr4.38 Cr5.98 Cr7.35 Cr
Total Liabilities -68.15 Cr120.14 Cr121.67 Cr121.69 Cr
Current Liabilities -22.54 Cr46.45 Cr37.94 Cr42.67 Cr
Long Term Debt -39.87 Cr63.85 Cr72.33 Cr61.43 Cr
Total Debt -49.94 Cr81.82 Cr89.45 Cr83.68 Cr
Total Equity -113.50 Cr143.58 Cr164.33 Cr210.43 Cr
Shares Outstanding -16.31 Cr16.31 Cr16.31 Cr16.31 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow -32.33 Cr38.42 Cr57.58 Cr79.10 Cr
Investing Cash Flow --47.99 Cr-55.91 Cr-50.94 Cr-16.93 Cr
Financing Cash Flow -15.84 Cr20.50 Cr-2.30 Cr-21.34 Cr
Capital Expenditure --44.11 Cr-75.27 Cr-63.88 Cr-16.64 Cr
Free Cash Flow --11.79 Cr-36.85 Cr-6.30 Cr62.46 Cr
Net Change in Cash -17.03 L3.01 Cr4.34 Cr40.83 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % -85.2%86.1%85.5%85.3%
Operating Margin % -22.2%21.8%16.4%21.7%
Net Margin % -17.2%17.3%9.3%15.3%
ROE % -23.5%21.2%13.0%22.2%
ROCE % -21.6%17.6%15.3%22.9%

Shareholding Pattern

Insiders
77.49%
Institutions
0.00%
Public Float
0.00%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for KMCSHIL

Google News ue, 18 Aug 2026

KMCSHIL Stock Price and Chart — NSE:KMCSHIL - TradingView

<a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTE5zV1FReUwyZU9hUmVncllXVjR6djJtUzJfUzY5LThpWEJwV0ZDNENwaWk2X0JJV1gyMTdKcTNob3hSRTlKMjBWdVVFdjJkOXdqMm1UVGhtX3paOWxu?oc=5" target="_blank">KMCSHIL Stock Price and Chart — NSE:KMCSHIL…

Google News ue, 18 Aug 2026

KMC Speciality Hospitals (India) Limited Trade Ideas — NSE:KMCSHIL - TradingView

<a href="https://news.google.com/rss/articles/CBMiZEFVX3lxTE1SR18xX2hmTVVsWHpYdzBrSmhXbEwzN3pPYnpGSDZBMkw4amFQaGJHZno1ODEwS0o0LVhLQ3d2NEptMUpTVER4YkpLaHZvTVAweEx4V3hscUVlalJoelM1VXlMUVc?oc=5" target="_blank">KMC Speciality Hospitals (India)…

Google News Mon, 25 May 2026

KMC FY26 net profit jumps 118% to ₹4,673 lakh on revenue growth - scanx.trade

<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxNb0JRNE1xU0NFUUVWUEtLcklKcmdUcU5KSHM2elhfcTB0Y1BsNzdUeERyVEdpRFNOQTl6Y2MtQ1BfNklpVjZTSEVSb1Qyd2dIRkxGNXBjZjFMamRCZjdwTV9DLXc3SFoxZVlnTEZDWlhuVlVtdWt5Nk9DQnRiakZULXJpWWJSWVhCVVY0SF…

Google News Wed, 19 Aug 2026

KMC Speciality Hospitals (India) Ltd (KMCSHIL) sentiment score, message volume, participation score and buzz level - Stocktwits

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE1TQTFOdDMwNHJXV0VpeFBnRzZEaDZMMDVNWDlmWEdnUkNWNXZwSGFXR0w1MXR1TVkzanpPLVNfRzVzbDQtMnlLYUlkMExSVmNkSTg5NVk3dTU3QTRzY282TA?oc=5" target="_blank">KMC Speciality Hospitals (India) Ltd …

Google News Wed, 19 Aug 2026

KMC Speciality Hospitals (India) Ltd (KMCSHIL) Fundamental and Financial Data - Stocktwits

<a href="https://news.google.com/rss/articles/CBMiZEFVX3lxTFB0N3BibnRsMWdUMXFvWTRSVUVyWkxLRUcwUWF4NTh3UEs2THZhakdNRVo1aWhOLXJJSGNOTGFQQlo4UENGQXVjMEZBa2Vqa2FsSnB6TUNGRDMyZXYyWng4ZjVocVc?oc=5" target="_blank">KMC Speciality Hospitals (India)…

Google News Mon, 25 Mar 2024

K M C SPECIALITY HOSP I L Share Price - Live NSE: KMCSHIL Stock Price & Chart - Upstox

<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTE1QZHE0dzE5UTh3MGh5SWVVWW04cHhKWWQxQ3RIVjRGNUlncjFSVThsYUdacXpaQWVmNk14ZnNfZGlOMmZ5NG1GWmpIYnRGeGk0VVpRQXEtcDdGWXhiWkozQmM5bm4tS3d0eW5XdjR4eFdyYjVJSU9B?oc=5" target="_blank">K M C S…

KMCSHIL — Frequently Asked Questions

What is the current share price of KMC Speciality Hospitals (India) Limited (KMCSHIL)?

As of 2026-09-08 04:53 IST, KMC Speciality Hospitals (India) Limited (KMCSHIL) trades at ₹138.24 on NSE. Its 52-week range is ₹133.19 to ₹141.97.

What is the market capitalisation of KMCSHIL?

KMC Speciality Hospitals (India) Limited (KMCSHIL) has a market capitalisation of ₹2,254.49 Cr on NSE.

What is the P/E ratio of KMCSHIL?

KMCSHIL trades at a trailing price-to-earnings (P/E) ratio of 48.17. Its price-to-book (P/B) ratio is 10.98.

What is the return on equity (ROE) of KMCSHIL?

KMCSHIL has a return on equity (ROE) of 22.21%. Its return on capital employed (ROCE) is 22.89%.

Is KMCSHIL a good stock to buy?

This page provides a data-driven analysis of KMC Speciality Hospitals (India) Limited (KMCSHIL), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space